NextGen Healthcare (NXGN) is exploring options that include a sale of the company and has hired investment bank Morgan Stanley (MS) to advise it on its discussions with potential buyers, people familiar with the matter told Reuters’ David Carnevali. There is no certainty that NextGen, a provider of software that helps manage patients’ records and has a market value of $1.1B, will reach a deal to sell itself, the sources added, according to the report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NXGN: